Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2

被引：0
作者：
Fang-Ju Cheng
Chien-Yi Ho
Tzong-Shiun Li
Yeh Chen
Yi-Lun Yeh
Ya-Ling Wei
Thanh Kieu Huynh
Bo-Rong Chen
Hung-Yu Ko
Chen-Si Hsueh
Ming Tan
Yang-Chang Wu
Hui-Chi Huang
Chih-Hsin Tang
Chia-Hung Chen
Chih-Yen Tu
Wei-Chien Huang
机构：
[1] China Medical University Hospital,Center for Molecular Medicine
[2] China Medical University,Graduate Institute of Biomedical Sciences
[3] China Medical University,School of Medicine
[4] China Medical University,Department of Biomedical Imaging and Radiological Science
[5] China Medical University Hsinchu Hospital,Division of Family Medicine, Physical Examination Center
[6] China Medical University Hsinchu Hospital,Department of Medical Research
[7] Show Chwan Memorial Hospital,Department of Plastic Surgery, and Innovation Research Center
[8] National Chung Hsing University,Graduate Institute of Biomedical Engineering
[9] National Chung Hsing University,Department of Food Science and Biotechnology
[10] University of California San Diego,Cognitive Science
[11] Taichung Girls’ Senior High School,Chinese Medicine Research and Development Center
[12] China Medical University Hospital,Graduate Institute of Integrated Medicine
[13] China Medical University,Department of Medical Laboratory Science and Biotechnology
[14] Asia University,Department of Chinese Pharmaceutical Science and Chinese Medicine Resources
[15] China Medical University,Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
[16] China Medical University Hospital,Department of Respiratory Therapy
[17] China Medical University,Drug Development Center
[18] China Medical University,undefined
来源：
Cell & Bioscience | / 13卷
关键词：
Eriodictyol; Umbelliferone; TMPRSS2; ACE2; SARS-CoV-2 variants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 396 条
  • [1] Del Rio C(2020)COVID-19-New insights on a rapidly changing epidemic JAMA 323 1339-1340
  • [2] Malani PN(2021)SARS-CoV-2 variants spike mutations and immune escape Nat Rev Microbiol 19 409-424
  • [3] Harvey WT(2020)The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nat Microbiol 5 536-544
  • [4] Carabelli AM(2021)Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic Lancet 398 2126-2128
  • [5] Jackson B(2022)Increased risk of SARS-CoV-2 reinfection associated with emergence of omicron in South Africa Science 376 eabn4947-1179
  • [6] Gupta RK(2022)SARS-CoV-2 omicron is an immune escape variant with an altered cell entry pathway Nat Microbiol 7 1161-782
  • [7] Thomson EC(2020)Structure of the RNA-dependent RNA polymerase from COVID-19 virus Science 368 779-904.e899
  • [8] Harrison EM(2020)Structural and functional basis of SARS-CoV-2 entry by using human ACE2 Cell 181 894-280.e278
  • [9] Ludden C(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor Cell 181 271-1263
  • [10] Reeve R(2020)Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Science 367 1260-784.e775
12345678910